YOKOGAWA-ELECTRIC
Yokogawa Electric Corporation (TOKYO:6841) announces that the Peru branch of Yokogawa América do Sul (a Yokogawa Electric Corporation subsidiary) has received a control system order from Técnicas de Desalinización de Aguas, S.A. (Tedagua)*1 for a water desalination plant and associated facilities that it is building for Servicio de Agua Potable y Alcantarillado de Lima S.A. (SEDAPAL) in the Santa Maria district of Lima, the capital of Peru.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190128005006/en/
With the Provisur seawater desalination project, Peru’s first reverse osmosis*2 desalination plant is being constructed to supply 35,000 m3 of potable water per day to the 100,000 residents of the Santa Maria district. Water distribution and sewer pipelines (total length: 260 km), a sewage treatment plant (daily capacity: 15,500 m3 ), and an undersea pipeline (780 m) for the discharge of treated water are also being built. Part of the treated water will be used for watering plants in the local area. Expectations are high for this project because Lima and other coastal areas in Peru have a desert climate that gets very little rain throughout the year.
Yokogawa will deliver the CENTUMTM VP integrated production control system, STARDOMTM FCN-500 network-based control system, and other solutions for monitoring and controlling the project’s desalination plant, sewage treatment plant, water distribution pipelines, sewer pipelines, and undersea pipeline. Both CENTUM VP and STARDOM FCN-500 are solutions in Yokogawa’s OpreXTM Control and Safety System family. The Peru branch of Yokogawa América do Sul will have overall responsibility for executing the systems side of this project, including engineering and commissioning. Delivery is scheduled for April and the plant is to start operation in June 2019.
To “ensure availability and sustainable management of water and sanitation for all” is one of the 17 sustainable development goals (SDGs) for the year 2030 that were adopted by the United Nations Sustainable Development Summit. There are urgent needs around the world to achieve high availability for water supply and water treatment systems. Yokogawa will leverage its know-how and solid track record in executing water supply and water treatment projects in Japan and desalination projects outside Japan to provide solutions that will ensure a stable supply of water and protect the environment in South America and other regions.
*1: A major engineering, procurement, and construction (EPC) company
specializing in desalination plants. They are a group company of ACS, a
major construction company in Spain.
*2: A method by which seawater
is passed through a special membrane to remove salinity and produce
fresh water
For more information
Industries -Water & Wastewater-
https://www.yokogawa.com/industries/water-wastewater/
Our
Approach to Sustainability
https://www.yokogawa.com/about/sustainability/policy/
Yokogawa
Joins Global 100 Most Sustainable Corporations in the World Index
https://www.yokogawa.com/pr/news/2019/pr-news-2019-0123-en.htm
About Yokogawa
Founded in 1915, Yokogawa engages in broad-ranging activities in the areas of measurement, control, and information. The industrial automation business provides vital products, services, and solutions to a diverse range of process industries including oil, chemicals, natural gas, power, iron and steel, and pulp and paper. With the life innovation business the company aims to radically improve productivity across the pharmaceutical and food industry value chains. The test & measurement, aviation, and other businesses continue to provide essential instruments and equipment with industry-leading precision and reliability. Yokogawa co-innovates with its customers through a global network of 113 companies spanning 61 countries, generating US$3.8 billion in sales in FY2017. For more information, please visit www.yokogawa.com
The names of corporations, organizations, products, services and logos herein are either registered trademarks or trademarks of Yokogawa Electric Corporation or their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190128005006/en/
Contact:
Yokogawa Electric Corporation Public Relations, Integrated Communications Center Yokogawa-pr@cs.jp.yokogawa.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AwardFares Launches Intelligent New Alert System for Award Flight Availability5.8.2025 08:00:00 CEST | Press release
AwardFares, the leading search platform for award flights, today launched a major upgrade to its alert system, giving users smarter tools to discover and book award availability faster. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804412041/en/ AwardFares' Timeline view provides a clear, color-coded visualization of daily award seat availability across different cabin classes, helping users easily spot trends and opportunities for flights. The new system includes two powerful features: Flex Alerts and Live Alerts. Together, they provide both flexibility and precision, helping travelers maximize their points and miles like never before. Flex Alerts are designed for the flexible traveler. Instead of requiring an exact route and date, users can set broad criteria such as "any airport in the US to Europe for an entire month.” AwardFares' AI-powered system intelligently identifies matching availability, focusing not just on
Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy5.8.2025 02:02:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) received approval from the U.S. Department of Energy (DOE) for an uprate amendment to its Calcasieu Pass LNG project. The uprate approval increases Calcasieu Pass’ permitted peak liquefaction capacity from 12.0 million tonnes per annum (MTPA) to 12.4 MTPA. “Venture Global thanks its regulators, including DOE, for their efforts in prioritizing and streamlining approvals for critical energy infrastructure projects. These multibillion dollar investments will be key as the United States strengthens global energy security and increases energy trade with our partners around the world,” said Venture Global CEO Mike Sabel. Calcasieu Pass, Venture Global’s first project, reached first LNG production in 2022 and began commercial operations in April 2025. The company’s second facility, Plaquemines LNG, began LNG production in December 2024. Venture Global’s third project, CP2, received DOE export authorization and FERC approval in March 2025 and May 2025, re
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain4.8.2025 22:01:00 CEST | Press release
– Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint –– Treatment with VX-993 was generally safe and well tolerated, with safety profile similar to placebo arm – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced topline results from its recently completed Phase 2, randomized, double-blind, placebo-controlled dose-ranging study evaluating the safety and efficacy of its investigational selective NaV1.8 pain signal inhibitor, VX-993, in treating acute pain after bunionectomy surgery. Treatment with VX-993 did not result in a statistically significant improvement on the primary endpoint of the time-weighted Sum of the Pain Intensity Difference from 0 to 48 hours (SPID48) compared to placebo. VX-993 was generally safe and well tolerated. Most adverse events (AEs) were mild to moderate, and there were no serious adverse events (SAEs) related to VX-993. Based on these results, Vertex will not progress
TOURISE Announces Cross-Sector Advisory Board to Champion Bold New Platform Rewriting the Rules of Tourism4.8.2025 20:53:00 CEST | Press release
Leaders from World Travel & Tourism Council (WTTC), Global Sustainable Tourism Council, Amadeus, TikTok, Six Senses, Cirque du Soleil, Turismede Barcelona, Liberty International, Wagonlit Travel, Once Billion Happy, the Saudi Tourism Authority (STA), and the Riyadh School of Tourism and Hospitality at the helm of TOURISE Advisory Board Formation of the Advisory Board reinforces TOURISE’s dedication to driving cross-sector global collaboration Advisory Board shape TOURISE summit agenda, ensuring high-impact global issues such as equity, geographical representation and sectoral diversity are in spotlight TOURISE, the bold new global tourism platform, has announced the members of its cross-sector Advisory Board, a powerhouse of industry titans guiding TOURISE’s strategic direction and shaping the agenda of the inaugural global summit taking place in Riyadh from 11-13 November, 2025. TOURISE is where cross-sector convergence begins, a platform where leaders and visionaries debate, collabor
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe4.8.2025 20:38:00 CEST | Press release
Concept Medical Inc., a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA’s IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical’s mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804524652/en/ Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Study Dr. Samin Sharma enrolled the first patient at New York’s Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom